Javascript must be enabled to continue!
Business Combinations
View through CrossRef
A business combination is a form of merging one company with another company in order to gain control over its assets and operations. The international accounting standards governing business combinations are IFRS 3 concerning Business Combinations. In Indonesia, business combinations are regulated in PSAK 22. IFRS 3 and PSAK 22 are relatively new standards to be applied in Indonesia, besides that these standards are quite complicated to apply to companies that carry out business combinations, therefore there are still few researchers who are interested in researching application of IFRS 3 especially in Indonesia. This research was conducted to analyze the application of IFRS 3 and PSAK 22 concerning Business Combinations according to decision theory studies with case studies on companies in Indonesia that carry out business combination activities, specifically PT PP Properti Tbk, PT Ciputra Development Tbk, and PT Kimia Farma (Persero) Tbk. This research was conducted using a comparative qualitative analysis method through case studies on three companies listed on the Indonesia Stock Exchange namely PT PP Properti Tbk, PT Ciputra Development Tbk and PT Kimia Farma (Persero) Tbk. The data used is secondary data in the form of company annual reports in 2017 and 2018. The data is processed using a qualitative descriptive analysis method to determine the impact of implementing IFRS 3 and PSAK 22 on companies. The results of the study show that the accounting treatment for business combinations at PT PP Properti Tbk, PT Ciputra Development Tbk, and PT Kimia Farma (Persero) Tbk is different, this is because the types of business combinations carried out by the three companies are different. The business combination carried out by PT PP Properti Tbk is an acquisition. Furthermore, the business combination carried out by PT Ciputra Development Tbk is a merger with entities under common control which is within the scope of PSAK 38. Then the business combination carried out by PT Kimia Farma (Persero) Tbk is the formation of a joint venture which is within the scope of PSAK 15. carried out by PT PP Properti Tbk is a business combination that is within the scope of IFRS 3 and PSAK 22. In the financial statements of PT PP Properti Tbk, presentations related to business combinations are in accordance with the implementation of IFRS 3 and PSAK 22 concerning Business Combinations.
Title: Business Combinations
Description:
A business combination is a form of merging one company with another company in order to gain control over its assets and operations.
The international accounting standards governing business combinations are IFRS 3 concerning Business Combinations.
In Indonesia, business combinations are regulated in PSAK 22.
IFRS 3 and PSAK 22 are relatively new standards to be applied in Indonesia, besides that these standards are quite complicated to apply to companies that carry out business combinations, therefore there are still few researchers who are interested in researching application of IFRS 3 especially in Indonesia.
This research was conducted to analyze the application of IFRS 3 and PSAK 22 concerning Business Combinations according to decision theory studies with case studies on companies in Indonesia that carry out business combination activities, specifically PT PP Properti Tbk, PT Ciputra Development Tbk, and PT Kimia Farma (Persero) Tbk.
This research was conducted using a comparative qualitative analysis method through case studies on three companies listed on the Indonesia Stock Exchange namely PT PP Properti Tbk, PT Ciputra Development Tbk and PT Kimia Farma (Persero) Tbk.
The data used is secondary data in the form of company annual reports in 2017 and 2018.
The data is processed using a qualitative descriptive analysis method to determine the impact of implementing IFRS 3 and PSAK 22 on companies.
The results of the study show that the accounting treatment for business combinations at PT PP Properti Tbk, PT Ciputra Development Tbk, and PT Kimia Farma (Persero) Tbk is different, this is because the types of business combinations carried out by the three companies are different.
The business combination carried out by PT PP Properti Tbk is an acquisition.
Furthermore, the business combination carried out by PT Ciputra Development Tbk is a merger with entities under common control which is within the scope of PSAK 38.
Then the business combination carried out by PT Kimia Farma (Persero) Tbk is the formation of a joint venture which is within the scope of PSAK 15.
carried out by PT PP Properti Tbk is a business combination that is within the scope of IFRS 3 and PSAK 22.
In the financial statements of PT PP Properti Tbk, presentations related to business combinations are in accordance with the implementation of IFRS 3 and PSAK 22 concerning Business Combinations.
Related Results
Oligogenic combinations of rare variants influence specific phenotypes in complex disorders
Oligogenic combinations of rare variants influence specific phenotypes in complex disorders
ABSTRACT
Genetic studies of complex disorders such as autism and intellectual disability (ID) are often based on enrichment of individual rare va...
Artificially Selected Grain Shape Gene Combinations in Guangdong Simiao Varieties of Rice (Oryza sativa L.)
Artificially Selected Grain Shape Gene Combinations in Guangdong Simiao Varieties of Rice (Oryza sativa L.)
Abstract
Background
Grain shape is a key trait in rice breeding. Although many QTLs and genes of grain shape have been identified, how different com...
Introduction: What Makes this Book Distinctive
Introduction: What Makes this Book Distinctive
Just Business: Business Ethics in Action by Elaine Sternberg is an unusual book on business ethics; the extract presented here, 'Introduction: What Makes This Book Distinctive', ex...
Deciphering molecular mechanisms of synergistic growth reduction in kinase inhibitor combinations
Deciphering molecular mechanisms of synergistic growth reduction in kinase inhibitor combinations
Abstract
In cancer treatment, the persistent challenge of unresponsiveness of certain patients to drugs or the development of resistance post-treatment remains a si...
Atypical business law provisions
Atypical business law provisions
The article is devoted to the vision of atypical business law provisions. It was found that the state of scientific opinion regarding atypical business law provisions is irrelevant...
BUSINESS MODEL AS A VALUE MANAGEMENT TOOL
BUSINESS MODEL AS A VALUE MANAGEMENT TOOL
Urgency of the research. In the crisis conditions of quarantine, business modelling has become the subject of scientific debate and demand from businesses. Applying conservative ap...
Optimal Effective Concentration Combinations and synergy evaluations for binary antimicrobial combinations in vitro
Optimal Effective Concentration Combinations and synergy evaluations for binary antimicrobial combinations in vitro
BackgroundThis study provides a comparative analysis of Optimal Effective Concentration Combinations (OPECCs) and synergy evaluations derived from the Loewe additivity and Bliss in...
Energy Measures as Biomarkers of SARS-CoV-2 Variants and Receptors
Energy Measures as Biomarkers of SARS-CoV-2 Variants and Receptors
The COVID-19 outbreak has made it evident that the nature and behavior of SARS-CoV-2 requires constant research and surveillance, owing to the high mutation rates that lead to vari...

